Search Results

Timo De Groof About Dr. Timo De Groof Dr. Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and During his Ph.D., Timo, together with Dr. Timo De Groof on the web LinkedIn Researchgate Twitter Medical Imaging Group Google Scholar Dr.

Workshop 2024 , hosted in the vibrant heart of Mexico City at the prestigious venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center for Research and Advanced Studies About the venue Cinvestav: Centro de investigación y de Estudios Avanzados del IPN Av. Preliminary Program Layout Date Time Title October 23, 2024 October 24, 2024 October 25, 2024 *Flash

Antony Boucard joined the Université de Sherbrooke (Québec, Canada) as a B.S. student of the Biochemistry Gaetan Guillemette in the Pharmacology department at the Université de Sherbrooke. Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN). He also actively volunteers as an Associate Professor of the non-governmental organization Institut des Sciences, des Technologies et des Etudes Avancées d’Haïti (ISTEAH) to help consolidate higher education

Medicine and the CEO of the Institute for Research in Immunology and Cancer ( IRIC ) at the Université de and a scholar of the Medical Research Council of Canada at the Faculty of Medicine of the Université de As some of you may know, Michel was one of my professors at the Universite de Montreal. I spent some time working in Michel’s lab with some of his postdocs and although I was never officially on the web Wikipedia IRIC Bouvier Lab Google Scholar Pubmed ResearchGate Twitter LinkedIn Universite de

biochemists Celtarys empowers medicinal biochemists by providing innovative fluorescent probes that de-risk She then joined the University of Santiago de Compostela as a postdoctoral researcher in Prof. and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools Boston, MA and Santiago de Fluorescent Probes Innovative fluorescent probes that de-risk the pre-clinical drug discovery phase with Mestre Mateo 2, Santiago de Compostela, 15706, Spain Email Website LinkedIn

Bianca Plouffe obtained her B.Sc. in Biochemistry in 2003 from Université de Sherbrooke (Qc, Canada). In 2006, Bianca obtained a Doctoral Scholarship from the Fonds de Recherche du Québec en Santé. Institutes of Health Research in 2012, Bianca joined the research group of Prof Michel Bouvier at Université de

Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel Bouvier at Université de

with our nonprofit team for expert guidance, trusted CRO collaborations, and field-tested tools that de-risk From pipeline acceleration and investment de-risking to CRO differentiation — turning GPCR complexity Explore CRO Bank Our Core Support Areas Discovery Consulting & Strategy Expert guidance to de-risk projects

Most importantly, the GPCR Retreat dedicates time for two trainee symposia, an initiative that began Conference History The GPCR Retreat is an annual joint meeting with the Club des récepteurs à Sept Domaines The following year, the Great Lakes GPCR Retreat partnered with the annual symposium of the Club des Montebello, the 22nd Annual Great Lakes G Protein-Coupled Receptor Retreat held jointly with the Club des

Fuel Discovery VC Due Diligence & De-risking For Venture Capital Firms De-risk GPCR Investments: Identify focused, scientific expertise that accelerates complex GPCR discovery programs, ensuring clarity and de-risking This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory delivering high-quality data across complex biotech programs, but translating that data into aligned, timely

an opioid receptor pharmacology group at the CHU Sainte-Justine Research Center and the Université de Research Center and a professor in the Department of Pharmacology and Physiology at the Université de She completed her PhD at McGill University with Claude de Montigny, working on serotonin and antidepressant mechanisms, and her postdoctoral training with Michel Bouvier at the Université de Montréal, where she

Every time, it’s a new world—and we’re still learning.” — Maria Majellaro Through this partnership, Celtarys She began as a medicinal chemist in Italy, but a postdoc opportunity in Santiago de Compostela—and a mentor’s timely suggestion—changed her trajectory. When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap predoctoral visiting student at the CIQUS Research Center—Campus of International Excellence—in Santiago de

He obtained his Ph.D. from the Université de Montréal in 2002 under the guidance of Dr.

Brian Kobilka's lab at Stanford University and the SFMB laboratory at the Université Libre de Bruxelles

"My contribution to science began during the equivalent of U.S. masters training at the Université de During this time, Dr. Sebag as an exchanged scholar while my student visa was in the work, during which time I thoroughly reviewed At the time, NanoBiT was a prototype technology we gained access to by collaborating with Promega. I also invested a tremendous amount of time in developing my leadership skills.

stall timelines without payoff Match experiments to the specific phase and risk tolerance of the asset De-risk Your CRO Strategy I evaluate, select, and manage CROs that are fit-for-purpose—saving you time, cost

receptors at the bench — training that spanned chemokine receptor conformational dynamics at the Université de collectively underserved by the infrastructure around it, and building that infrastructure has become a full-time She holds a PhD in Biochemistry from the Université de Montréal, where she trained in Dr. "Brian throughout his career was told so many times that he should quit science.

From Many to One: De-Orphanization and Precision Focus “You can use this system to de-orphanize receptors

His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016

Aurélien Rizk co-founded Algorizk, a company that created real-time physics simulations for education in mathematics, physics, and computer science at the French Grande École, École Normale Supérieure de They highlighted that while there was a time when biology lagged due to the lack of appropriate tools Technology Evolution and Ligand Residence Time Prediction Yamina Berchiche and Aurelien Rizk discussed The conversation also revolved around the company's ability to predict the residence time of a ligand

Monitor GPCR internalization in real time with pHSense™ – no-wash, TR-FRET reagents from Revvity. Unlock microscopy-free real-time GPCR internalization with pHSense pHSense™ probes are optimized reagents for plate readers, specifically designed to study internalization using time-resolved fluorescence ( Time-Resolved Fluorescence (TRF) = High Signal-to-Background: Europium’s long-lived fluorescence allows degree in biology and biotechnology engineering from the University of Sciences of Nîmes and the Ecole des

Scientific Officer and co-founder of Celtarys Research , a biotech spin-off from the University of Santiago de

development leader with extensive experience driving drug discovery teams in bringing biologics to clinical proof

By using our Website, you agree to fully comply with and be bound by the following ATS each time you GPCR reserves the right to modify these Legal Policies and Disclaimers from time to time without prior You can review the most current versions at any time on our Website.

Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that John started grad school in 1999 and spent some time figuring out what he was interested in.

I'm genuinely interested to see how it evolves and grows over time, as I feel it has the potential to Anonymous This came at just the most perfect time. I've listened to the episodes multiple times and it's just like being at a conference getting new ideas Am very grateful for Dr GPCR livening up the week in these difficult times!

Make a Contribution Secure via Wix Payments - Tax-deductible - One-time or recurring Where Your Donation Become a Partner Donate Frequency One time One time Monthly Monthly Yearly Yearly Amount $25 $25 $250 Monthly donations sustain long-term programs and can be changed at any time through the donation form

Her team at InterAx models receptor signaling pathways as systems of time-dependent equations, then runs signaling pathways Pharmacological fingerprints as multi-parameter compound descriptors Ligand residence time Standard assay kits that read cAMP at thirty minutes or arrestin recruitment at ten collapse time-resolved Picking a single time point for a single pathway and computing a bias factor captures far less than looking at how several pathways evolve over time — especially for compounds with unusual kinetics.

During my time in London I investigated regulatory mechanisms of GPCR action, namely dimerization and Still working on GPCR trafficking but this time in neurons.

Report an Incident Thank you for taking the time to report any incidents or issues you are experiencing